文献速递肿瘤 PET/CT神经核医学

68Ga-DOTATOC与卡比多巴辅助18F-DOPA PET/CT定位胰岛素瘤的价值

Value of 68Ga-DOTATOC and Carbidopa-Assisted 18F-DOPA PET/CT for Insulinoma Localization.
PubMed 文献 · J Nucl Med · 2021-07-16

回顾性分析21例低血糖患者,均行68Ga-DOTATOC和卡比多巴辅助18F-DOPA PET/CT。最终12例确诊胰岛素分泌肿瘤,18F-DOPA和68Ga-DOTATOC阳性分别为5例(45%)和7例(64%)。结论:无68Ga-exendin-4时,68Ga-生长抑素受体PET/CT应作为胰岛素瘤功能显像首选。

要点

  • 68Ga-DOTATOC阳性率64%(7/11),高于18F-DOPA的45%(5/11)。
  • 4例两者均阳性,1例仅18F-DOPA阳性,3例仅68Ga-DOTATOC阳性。
  • 两者各出现1例假阳性(无功能胰腺神经内分泌肿瘤)。

核心结论

  • 无68Ga-exendin-4时,68Ga-生长抑素受体PET/CT应作为胰岛素瘤功能显像的首选。

研究设计与样本

  • 回顾性分析2019年1月至2021年1月因怀疑胰岛素瘤行68Ga-DOTATOC或卡比多巴辅助18F-DOPA PET/CT的21例低血糖患者。
  • 最终诊断由病理报告或共识确定,12例确诊胰岛素分泌肿瘤(11例胰岛素瘤和1例小混合性神经内分泌/非神经内分泌肿瘤)。

主要发现

  • 18F-DOPA和68Ga-DOTATOC PET/CT在11例中分别阳性5例(45%)和7例(64%),4例两者均阳性。
  • 1例胰岛素瘤仅由18F-DOPA PET/CT显示,3例仅由68Ga-DOTATOC PET/CT显示。
  • 18F-DOPA和68Ga-DOTATOC PET/CT在1例无功能胰腺神经内分泌肿瘤中均出现假阳性。

关键数值与推荐

  • 18F-DOPA PET/CT阳性率45%(5/11),68Ga-DOTATOC PET/CT阳性率64%(7/11)。

临床怎么用

  • 在68Ga-exendin-4不可及时,优先选用68Ga-生长抑素受体PET/CT进行胰岛素瘤功能显像。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Our objective was to assess the value of 68Ga-DOTATOC and carbidopa-assisted 18F-fluorodihydroxyphenylalanine (18F-DOPA) in 21 hypoglycemic patients. Methods: All patients who underwent 68Ga-DOTATOC or carbidopa-assisted 18F-DOPA PET/CT for suspicion of insulinoma from January 2019 to January 2021 were retrospectively analyzed. A final diagnosis of insulinoma was determined by pathologic reports or consensus. Results: During the study period, 21 patients underwent both 68Ga-DOTATOC and 18F-DOPA PET/CT. A final diagnosis of insulin-secreting tumor was reached in 12 cases, including 11 insulinomas and 1 small mixed neuroendocrine/nonneuroendocrine neoplasm. 18F-DOPA and 68Ga-DOTATOC PET/CT were positive in 5 (45%) and 7 (64%) of 11 cases, respectively, with 4 concordant positive findings. Moreover, 1 insulinoma was visualized exclusively by 18F-DOPA PET/CT and 3 by 68Ga-DOTATOC PET/CT only. 18F-DOPA and 68Ga-DOTATOC PET/CT were falsely positive in 1 nonfunctioning pancreatic neuroendocrine tumor. Conclusion: When 68Ga-exendin-4 is not available, 68Ga-somatostatin receptor PET/CT should be the first choice for insulinoma functional imaging.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Imperiale A, Boursier C, Sahakian N, et al. Value of 68Ga-DOTATOC and Carbidopa-Assisted 18F-DOPA PET/CT for Insulinoma Localization. J Nucl Med. 2021. PMID: 34272321. doi:10.2967/jnumed.121.262401

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。